Jacques Tapiero has sold MKC and made no open-market buys since Aug 2019

Jacques Tapiero is an accomplished executive in the pharmaceutical and consumer goods industries, born in 1958 with US and Swiss nationality.( He earned a degree in Business Administration and Management from École Supérieure de Commerce de Clermont-Ferrand, France, and an MBA from Thunderbird School of Global Management in 1982.( Tapiero spent over 30 years at Eli Lilly and Company, advancing to Senior Vice President and President of Emerging Markets, overseeing operations in high-growth regions like China, Russia, Brazil, Mexico, South Korea, and Turkey, managing a turnover exceeding $2.5 billion across 70 countries.( He held key leadership roles including Managing Director at Eli Lilly Sweden AB (1993-1995), President & General Manager at Eli Lilly do Brasil Ltda. (1995-1999) and Lilly France SAS (2000-2004).(

Since 2012, Tapiero has served as an Independent Director at McCormick & Co., Inc. (MKC), recently engaging in insider trading activity, including selling 5,000 shares on November 11, 2024, and holding approximately 2,620 shares as of late 2024 valued at around $186,308.( He also holds directorships at Esteve Pharmaceuticals S.A. and Lead Director at Esteve Healthcare SL, serves as a senior consultant at McKinsey & Company, advisor at GLG Institute, and member of the executive directorate at Thunderbird School of Global Management.(

Written by Perplexity from public sources.